Recurrent Clostridium difficile infection treated with bezlotoxumab in a liver transplant patient
Gastroenterol Hepatol. 2021 Dec;44(10):720-721.
doi: 10.1016/j.gastrohep.2020.09.015.
Epub 2020 Oct 22.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Aparato Digestivo, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España. Electronic address: mhernandezainsa@gmail.com.
- 2 Servicio de Aparato Digestivo, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
- 3 Servicio de Aparato Digestivo, Hospital General San Jorge, Huesca, España.
No abstract available
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Antibodies, Monoclonal / therapeutic use*
-
Broadly Neutralizing Antibodies / therapeutic use*
-
Clostridioides difficile*
-
Clostridium Infections / therapy*
-
Humans
-
Male
-
Middle Aged
-
Recurrence
-
Vancomycin / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Antibodies, Monoclonal
-
Broadly Neutralizing Antibodies
-
bezlotoxumab
-
Vancomycin